ConductScience.org, home

Paper29463546

Treatment with Atorvastatin Provides Additional Benefits to Imipenem in a Model of Gram-Negative Pneumonia Induced by Klebsiella pneumoniae in Mice.

de Paula TP and 10 others. Antimicrob Agents Chemother, 2018. Cited by 12 papers, by iCite.

Cite this record

ConductScience Library. Treatment with Atorvastatin Provides Additional Benefits to Imipenem in a Model of Gram-Negative Pneumonia Induced by Klebsiella pneumoniae in Mice. Papers, record 29463546. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/29463546

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Treatment with Atorvastatin Provides Additional Benefits to Imipenem in a Model of Gram-Negative Pneumonia Induced by Klebsiella pneumoniae in Mice.
PubMed
Journal
Antimicrob Agents Chemother
PubMed
Year
2018
PubMed
Publication types
Journal Article, Research Support, Non-U.S. Gov't
PubMed
Citations, by iCite
12
iCite
Relative citation ratio, by iCite
0.52
iCite
Revised in PubMed
2019-07-15
PubMed

Authors11

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1de Paula TPTalles Prosperi
2Santos PCPatrícia Campi
3Arifa RDDNRaquel Duque do Nascimento
4Vieira ATAngélica T
5Baltazar LMLudmila de Matos
6Ávila TVThiago Vinícius
7Fagundes CTCaio Tavares
8Garcia ZMZélia Menezes
9Lima RLRenata Lacerda
10Teixeira MMMauro Martins
11Souza DGDanielle Ghttps://orcid.org/0000-0002-7478-5934

Source PubMed

Download CSV of authors

Topics20

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Anti-Bacterial AgentsMajor topic
AtorvastatinMajor topic
Hydroxymethylglutaryl-CoA Reductase InhibitorsMajor topic
ImipenemMajor topic
Klebsiella InfectionsMajor topic
Klebsiella pneumoniaeMajor topic
Pneumonia, BacterialMajor topic
Animals
Bacterial Load
Chemokines
Community-Acquired Infections
Drug Resistance, Multiple, Bacterial
Drug Therapy, Combination
Female
Inflammation
Macrophages
Mice
Mice, Inbred C57BL
Neutrophils
Phagocytosis

Source PubMed

Download CSV of topics

References68

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
120937845CXCL1 regulates pulmonary host defense to Klebsiella Infection via CXCL2, CXCL5, NF-kappaB, and MAPKs.J Immunol2010https://conductscience.org/library/papers/20937845PubMed
215023865Sponge-induced angiogenesis and inflammation in PAF receptor-deficient mice (PAFR-KO).Br J Pharmacol2004https://conductscience.org/library/papers/15023865PubMed
312860913Statins promote potent systemic antioxidant effects through specific inflammatory pathways.Circulation2003https://conductscience.org/library/papers/12860913PubMed
416877692Potential therapeutic role for statins in respiratory disease.Thorax2006https://conductscience.org/library/papers/16877692PubMed
519608720Simvastatin inhibits airway hyperreactivity: implications for the mevalonate pathway and beyond.Am J Respir Crit Care Med2009https://conductscience.org/library/papers/19608720PubMed
621977167Mortality Risk and Etiologic Spectrum of Community-acquired Pneumonia in Hospitalized Adult Patients.Maedica (Bucur)2010https://conductscience.org/library/papers/21977167PubMed
720659133Effect of pravastatin on bleomycin-induced acute lung injury and pulmonary fibrosis.Clin Exp Pharmacol Physiol2010https://conductscience.org/library/papers/20659133PubMed
810448890Effects of tachykinin NK1 or PAF receptor blockade on the lung injury induced by scorpion venom in rats.Eur J Pharmacol1999https://conductscience.org/library/papers/10448890PubMed
916269144Effect of pravastatin, simvastatin and atorvastatin on the phagocytic activity of mouse peritoneal macrophages.Exp Mol Pathol2006https://conductscience.org/library/papers/16269144PubMed
1011699592Protection against pulmonary infection with Klebsiella pneumoniae in mice by interferon-gamma through activation of phagocytic cells and stimulation of production of other cytokines.J Med Microbiol2001https://conductscience.org/library/papers/11699592PubMed
1127040132Cholesterol Lowering in Intermediate-Risk Persons without Cardiovascular Disease.N Engl J Med2016https://conductscience.org/library/papers/27040132PubMed
1215998696Statin treatment after onset of sepsis in a murine model improves survival.Circulation2005https://conductscience.org/library/papers/15998696PubMed
1322379035Intrapulmonary administration of leukotriene B(4) augments neutrophil accumulation and responses in the lung to Klebsiella infection in CXCL1 knockout mice.J Immunol2012https://conductscience.org/library/papers/22379035PubMed
1422564676Antibacterial activity of statins: a comparative study of atorvastatin, simvastatin, and rosuvastatin.Ann Clin Microbiol Antimicrob2012https://conductscience.org/library/papers/22564676PubMed
1522054338Risk of pneumonia in patients taking statins: population-based nested case-control study.Br J Gen Pract2011https://conductscience.org/library/papers/22054338PubMed
1625869507Combined treatment with atorvastatin and imipenem improves survival and vascular functions in mouse model of sepsis.Vascul Pharmacol2015https://conductscience.org/library/papers/25869507PubMed
1722210917Transient TLR activation restores inflammatory response and ability to control pulmonary bacterial infection in germfree mice.J Immunol2012https://conductscience.org/library/papers/22210917PubMed
1816341063Anti-inflammatory effects of statins: clinical evidence and basic mechanisms.Nat Rev Drug Discov2005https://conductscience.org/library/papers/16341063PubMed
1911943658Killing of Klebsiella pneumoniae by human alveolar macrophages.Am J Physiol Lung Cell Mol Physiol2002https://conductscience.org/library/papers/11943658PubMed
209237044Enhancement of membrane fluidity in cholesterol-poor endothelial cells pre-treated with simvastatin.Endothelium1997https://conductscience.org/library/papers/9237044PubMed

See all 68 referencesDownload CSV of references

Cited by11

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 12 citations.

PMIDTitleJournalYearIn PapersSource
42800805Gut microbiota-derived acetate mitigates Escherichia fergusonii-induced gut dysbiosis exacerbating Klebsiella pneumoniae pulmonary infection in mice.Commun Biol2026https://conductscience.org/library/papers/42800805PubMed
41165829A novel anti-acute lung injury mechanism of astilbin: inhibition of epithelial cells ferroptosis by targeting NRF2 activation via binding Val608 site of NRF2.Inflamm Res2025https://conductscience.org/library/papers/41165829PubMed
41011446New Frontiers for Old Medications: Repurposing Approved Drugs Against Gram-Negative Bacterial Infections.Microorganisms2025https://conductscience.org/library/papers/41011446PubMed
37760764Repositioning of HMG-CoA Reductase Inhibitors as Adjuvants in the Modulation of Efflux Pump-Mediated Bacterial and Tumor Resistance.Antibiotics (Basel)2023https://conductscience.org/library/papers/37760764PubMed
36695576Treatment of Bacterial Infections with β-Lactams: Cooperation with Innate Immunity.Infect Immun2023https://conductscience.org/library/papers/36695576PubMed
36287114Autophagy, cell death, and cytokines in K. pneumoniae infection: therapeutic perspectives.Emerg Microbes Infect2023https://conductscience.org/library/papers/36287114PubMed
36160241Variability of murine bacterial pneumonia models used to evaluate antimicrobial agents.Front Microbiol2022https://conductscience.org/library/papers/36160241PubMed
33906301Antiangiogenic and Proapoptotic Activities of Atorvastatin and Ganoderma lucidum in Tumor Mouse Model via VEGF and Caspase-3 Pathways.Asian Pac J Cancer Prev2021https://conductscience.org/library/papers/33906301PubMed
33046059Pretreatment with atorvastatin ameliorates cobra venom factor-induced acute lung inflammation in mice.BMC Pulm Med2020https://conductscience.org/library/papers/33046059PubMed
32380052Granulocyte-targeted therapies for airway diseases.Pharmacol Res2020https://conductscience.org/library/papers/32380052PubMed
31315875Systematic review with a meta-analysis: clinical effects of statins on the reduction of portal hypertension and variceal haemorrhage in cirrhotic patients.BMJ Open2019https://conductscience.org/library/papers/31315875PubMed

Download CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/29463546

GET https://conductscience.org/api/papers/v1/29463546/references?page=2